Kayyem Jon Faiz
SEC CIK 1366268 · EDGAR
BoughtSold
Most active insiders at INBX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Viking Global Opportunities Parent GP LLC | 10% | — | $11.29M |
| 2 | Lappe Mark | CEO, Dir | $2.65M | — |
| 3 | Kayyem Jon Faiz | Dir | $1.57M | — |
| 4 | FORSYTH DOUGLAS | Dir | $286.6K | — |
| 5 | MANHARD KIMBERLY | Dir | — | $279.0K |
Transactions 15
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-09-23 16:59 | 2026-09-23 | INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Dir | P - Purchase | $100.00 | +5,000 | 434.4K | +1% | +$500.0K |
| I | 2026-09-17 17:46 | 2026-09-16 | INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Dir | P - Purchase | $100.00 | +5,000 | 429.4K | +1% | +$500.0K |
| I | 2026-09-08 17:23 | 2026-09-08 | INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Dir | P - Purchase | $113.52 | +5,000 | 424.4K | +1% | +$567.6K |
| I | 2025-03-28 | 2025-03-27 | INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Dir | G - Gift | $0.00 | -90.0K | 419.4K | -18% | $0 |
| MI | 2024-12-17 | 2024-12-16 | INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Dir | G - Gift | $0.00 | 0 | 250.0K | New | $0 |
| I | 2024-12-06 | 2024-12-06 | INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Dir | G - Gift | $0.00 | -52.0K | 1.01M | -5% | $0 |
| MI | 2024-11-22 | 2024-11-19+ | INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Dir | P - Purchase | $14.22 | +107.2K | 51.1K | New | +$1.52M |
| MI | 2024-06-24 | 2024-06-24 | INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Dir | G - Gift | $0.00 | -69.0K | 16.2K | -81% | $0 |
| MI | 2024-06-07 | 2024-06-05 | INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Dir | P - Purchase | $17.32 | +57.5K | 1.14M | +5% | +$997.0K |
| MI | 2024-06-04 | 2024-05-31+ | INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Dir | P - Purchase | $17.18 | +286.8K | 923.1K | +45% | +$4.93M |
| DMI | 2024-05-30 | 2024-05-29 | INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Dir | A - Grant | — | +818.6K | 6,250 | New | — |
| I | 2023-08-07 | 2023-08-03 | BDSX | BIODESIX INC | Kayyem Jon Faiz | Dir | A - Grant | $1.62 | +6,172 | 180.1K | +4% | +$9,999 |
| D | 2023-04-04 | 2023-03-31 | BDSX | BIODESIX INC | Kayyem Jon Faiz | Dir | M - OptEx | — | +145.8K | 177.5K | +461% | — |
| D | 2022-12-22 | 2022-12-21 | BDSX | BIODESIX INC | Kayyem Jon Faiz | Dir | M - OptEx | — | +31.6K | 31.6K | New | — |
| I | 2022-11-21 | 2022-11-21 | BDSX | BIODESIX INC | Kayyem Jon Faiz | Dir | P - Purchase | $1.15 | +173.9K | 173.9K | New | +$200.0K |